OTC nasal spray seemed to cut COVID infections by 67% in mid-sized trial - Ars Technica

[Top stories - Google News]

1. OTC nasal spray seemed to cut COVID infections by 67% in mid-sized trial Ars Technica
2. Covid infection may be prevented with a common nasal antihistamine spray, trial shows NBC News
3. Widely available nasal spray reduces risk of coronavirus infection by two-thirds, clinical study suggests Medical Xpress
4. This over-the-counter nasal spray already on shelves can reduce your risk of COVID: study New York Post
5. Interferon Alpha Nasal Spray Decreases COVID-19 Risk in Those With Cancer CancerNetwork

Continue reading...

 

Join 𝕋𝕄𝕋 on Telegram
Channel PREVIEW: